IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 225 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $80,320 | -56.5% | 10,015 | -55.9% | 0.02% | -68.1% |
| Q4 2023 | $184,649 | +152.4% | 22,712 | +41.3% | 0.05% | +113.6% |
| Q3 2023 | $73,159 | -56.2% | 16,079 | -7.7% | 0.02% | -66.2% |
| Q3 2022 | $167,000 | -42.2% | 17,419 | +0.2% | 0.06% | -59.6% |
| Q1 2022 | $289,000 | +21.4% | 17,380 | +39.5% | 0.16% | +15.0% |
| Q4 2021 | $238,000 | -19.9% | 12,462 | +3.5% | 0.14% | -25.1% |
| Q3 2021 | $297,000 | +40.8% | 12,035 | +56.9% | 0.19% | -33.0% |
| Q2 2020 | $211,000 | -35.9% | 7,670 | -35.4% | 0.28% | +5.3% |
| Q4 2019 | $329,000 | +41.8% | 11,878 | -13.4% | 0.26% | +373.2% |
| Q1 2018 | $232,000 | – | 13,713 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,019,201 | $26,720,000 | 20.38% |
| Broadfin Capital, LLC | 5,951,153 | $52,668,000 | 6.92% |
| GREAT POINT PARTNERS LLC | 5,567,348 | $49,271,000 | 6.23% |
| Avoro Capital Advisors LLC | 10,261,039 | $90,810,000 | 5.43% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $19,367,000 | 5.00% |
| Prosight Management, LP | 1,062,500 | $9,403,000 | 4.85% |
| Perceptive Advisors | 12,241,111 | $108,333,000 | 4.12% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,850,000 | 3.21% |
| QVT Financial LP | 1,021,361 | $8,696,000 | 2.84% |
| Vivo Capital, LLC | 1,600,000 | $14,160,000 | 1.81% |